295 related articles for article (PubMed ID: 2488876)
1. Leprosy.
Rea TH; Modlin RL
Immunol Ser; 1989; 46():723-45. PubMed ID: 2488876
[No Abstract] [Full Text] [Related]
2. Investigations related to the development of a leprosy vaccine.
Convit J; Aranzazu N; Ulrich M; Zúñiga M; de Aragón ME; Alvarado J; Reyes O
Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):531-9. PubMed ID: 6231259
[No Abstract] [Full Text] [Related]
3. A longitudinal study of immunologic reactivity in leprosy patients treated with immunotherapy.
Rada E; Ulrich M; Aranzazu N; Santaella C; Gallinoto M; Centeno M; Rodriguez V; Convit J
Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):552-8. PubMed ID: 7868953
[TBL] [Abstract][Full Text] [Related]
4. Research in leprosy. A report of a committee set up by the medical research council to study future prospects.
Clin Exp Immunol; 1979 Apr; 36(1):1-7. PubMed ID: 380853
[TBL] [Abstract][Full Text] [Related]
5. Reversal reaction in lepromatous patients induced by a vaccine containing killed ICRC bacilli--a report of five cases.
Bhatki WS; Chulawala RG; Bapat CV; Deo MG
Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):466-72. PubMed ID: 6368413
[TBL] [Abstract][Full Text] [Related]
6. Antileprosy potentials of ICRC vaccine. A study in patients and healthy volunteers.
Deo MG; Bapat CV; Bhalerao V; Chaturvedi RM; Bhatki WS; Chulawala RG
Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):540-9. PubMed ID: 6368417
[No Abstract] [Full Text] [Related]
7. Potential anti-leprosy vaccine from killed ICRC bacilli--a clinicopathological study.
Deo MG; Bapat CV; Chullawalla RG; Bhatki WS
Indian J Med Res; 1981 Aug; 74():164-77. PubMed ID: 7030942
[No Abstract] [Full Text] [Related]
8. Quantitative relationship between anti-PGL-I-specific antibody levels and the lepromin reaction.
David HL; Maroja M F; Cruaud P
Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):332-4. PubMed ID: 2071994
[No Abstract] [Full Text] [Related]
9. Immunotherapy of far-advanced lepromatous leprosy patients with low-dose convit vaccine along with multidrug therapy (Calcutta trial).
Majumder V; Mukerjee A; Hajra SK; Saha B; Saha K
Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):26-36. PubMed ID: 8627110
[TBL] [Abstract][Full Text] [Related]
10. Vaccines against leprosy.
Talwar GP
Asian Pac J Allergy Immunol; 1985 Dec; 3(2):137-9. PubMed ID: 3907649
[No Abstract] [Full Text] [Related]
11. An eight-year field trial on antileprosy vaccines among high-risk household contacts in the Calcutta metropolis.
Chaudhury S; Hazra SK; Saha B; Mazumder B; Biswas PC; Chattopadhya D; Saha K
Int J Lepr Other Mycobact Dis; 1994 Sep; 62(3):389-94. PubMed ID: 7963911
[TBL] [Abstract][Full Text] [Related]
12. Immunological reactions to mycobacterial proteins in the spectrum of leprosy.
Rada EM; Aranzazu N; Convit J
Int J Lepr Other Mycobact Dis; 1997 Dec; 65(4):497-500. PubMed ID: 9465162
[No Abstract] [Full Text] [Related]
13. Immunoprophylactic trial with combined Mycobacterium leprae/BCG vaccine against leprosy: preliminary results.
Convit J; Sampson C; Zúñiga M; Smith PG; Plata J; Silva J; Molina J; Pinardi ME; Bloom BR; Salgado A
Lancet; 1992 Feb; 339(8791):446-50. PubMed ID: 1346818
[TBL] [Abstract][Full Text] [Related]
14. Antileprosy protective vaccination of rhesus monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: immunologic observations.
Gormus BJ; Baskin GB; Xu K; Ratterree MS; Martin LN; Mack PA; Bohm RP; Meyers WM; Walsh GP
Int J Lepr Other Mycobact Dis; 2000 Mar; 68(1):27-39. PubMed ID: 10834067
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy of lepromin-negative borderline leprosy patients with low-dose Convit vaccine as an adjunct to multidrug therapy; a six-year follow-up study in Calcutta.
Chaudhury S; Hajra SK; Mukerjee A; Saha B; Majumdar V; Chattapadhya D; Saha K
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):56-62. PubMed ID: 9207754
[TBL] [Abstract][Full Text] [Related]
16. Histologic responses in sixty multibacillary leprosy patients inoculated with autoclaved Mycobacterium leprae and live BCG.
Meyers WM; McDougall AC; Fleury RN; Neves R; Reyes O; Binford CH
Int J Lepr Other Mycobact Dis; 1988 Jun; 56(2):302-9. PubMed ID: 3045226
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies and recombinant DNA technology: present and future uses in leprosy and tuberculosis.
Seckl MJ
Int J Lepr Other Mycobact Dis; 1985 Dec; 53(4):618-40. PubMed ID: 3910750
[No Abstract] [Full Text] [Related]
18. Immunology and animal experimentation in leprosy.
Shepard CC
Cutis; 1976 Jul; 18(1):80-96. PubMed ID: 797549
[No Abstract] [Full Text] [Related]
19. IgM antibodies against phenolic glycolipid I from Mycobacterium leprae in leprosy sera: relationship to bacterial index and erythema nodosum leprosum.
Schwerer B; Meeker HC; Sersen G; Levis WR
Acta Leprol; 1984; 2(2-4):394-402. PubMed ID: 6398598
[TBL] [Abstract][Full Text] [Related]
20. Studies on healthy contacts of leprosy patients--a preliminary report.
Ramu G; Malaviya GN; Bharadwaj VP; Sengupta U; Sinha S; Ramanathan VD; Pal C; Desikan KV
Indian J Lepr; 1985; 57(4):796-803. PubMed ID: 3915008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
